Long-term Response of <i>Helicobacter pylori</i> Antibody Titer After Eradication Treatment in Middle-aged Japanese: JPHC-NEXT Study
Shiori Tanaka, Shoichiro Tsugane(International University of Health and Welfare), Kiyoshi Aoyagi(Nagasaki University), Motoki Iwasaki, Kazuhiko Arima, Kazumasa Yamagishi(University of Tsukuba), Taiki Yamaji, Atsushi Goto, Kozo Tanno(Iwate Medical University), Norie Sawada(National Cancer Center), Nobufumi Yasuda(Kōchi University), Hiroyasu Iso(National Center for Global Health and Medicine), Kiyomi Sakata, Manami Inoue(Fukuoka University), Isao Muraki(The University of Osaka), Taichi Shimazu, Tadahiro Kato(Ehime University), Isao Saito(Oita University)
Cited by 18
Related Papers
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
|The Lancet|2012|1.4k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
|The Lancet Diabetes & Endocrinology|2015|897